Skip to main content

CERETEC

Generic: TECHNETIUM TC-99M EXAMETAZIME

Verified·Apr 23, 2026
Manufacturer
GE Healthcare
NDC
17156-022
Route
INTRAVENOUS
ICD-10 indication
I63.9

Affordability Check

How much will you actually pay for CERETEC?

In 30 seconds, see every legitimate way to afford CERETEC — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About CERETEC

What is this medication? Ceretec, also known by the generic name technetium Tc-99m exametazime, is a radiopharmaceutical diagnostic agent used in medical imaging. It is primarily utilized during single photon emission computed tomography (SPECT) scans to evaluate blood flow within the brain. This procedure helps healthcare professionals identify and assess various conditions such as strokes, certain types of dementia, or other neurological disorders by providing clear visual data on cerebral perfusion.

In addition to brain imaging, this medication is frequently used to label white blood cells, specifically leukocytes, for injection back into the patient. Once the labeled cells are reintroduced, they migrate to sites of infection or inflammation within the body. This process allows physicians to pinpoint the location of internal abscesses or inflammatory bowel disease using specialized imaging equipment, aiding in the diagnosis and management of complex infections.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for CERETEC. Official source: DailyMed (NLM) · Label effective Jan 10, 2024

Indications and usage
INDICATIONS AND USAGE Technetium Tc99m exametazime scintigraphy may be useful as an adjunct in the detection of altered regional cerebral perfusion in stroke. Tc99m exametazime is indicated for leukocyte labeled scintigraphy as an adjunct in the localization of intra-abdominal infection and inflammatory bowel disease.
Dosage and administration
DOSAGE AND ADMINISTRATION Tc99m labeled leukocytes for adjunctive localization of intra-abdominal infection or inflammation. The normal adult (70 kg) dose is 0.259-0.925 GBq (7-25 mCi) as Tc99m labeled leukocytes by intravenous injection. Optimal planar imaging is between 2-4 hours. Cerebral Scintigraphy The recommended dose range for i.v. administration, of reconstituted sodium pertechnetate Tc99m exametazime in the average adult (70 kg) is 370-740 MBq (10-20 mCi). Dynamic imaging may be performed between 0 to 10 minutes following injection. Static imaging may be performed from 15 minutes up to 6 hours after injection.
Contraindications
CONTRAINDICATIONS None known.
Adverse reactions
ADVERSE REACTIONS Rash with generalized erythema, facial edema and fever has been reported in less than 1% of patients. A transient increase in blood pressure was seen in 8% of patients.
Use in pregnancy
Pregnancy Category C Animal reproduction studies have not been conducted with Tc99m exametazime. It is also not known whether Tc99m exametazime can cause fetal harm when administered to a pregnant woman or if it can affect reproductive capacity. Therefore, Tc99m exametazime should not be administered to a pregnant woman unless the potential benefit justifies the potential risk to the fetus.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.